RT-310 Dose Escalation BPH Study

Summary

RT-310, a novel implant, is intended to minimally invasive treat locally the prostate gland for the management of prostate disease, while minimizing side-effects. The objectives of the study are to assess whether RT-310 is safe and feasible for the participant population.

Timeline

Start

2024-04-19

Primary completion

2025-12

Completion

2027-12

Drugs

Indications